K
Keros Therapeutics (KROS)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Keros Therapeutics (KROS)
Keros Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of treatments for patients suffering from hematological and musculoskeletal disorders with high unmet m... Read more
- USD56.15
- USD58.69
- USD54.93
- USD73.00
- -16.20%
- 0M
- 1.00
- 275.64k
- 2.1B
- 27.02
- 21.90%
Stock News
24 minutes ago
U.S. crude oil pulls back below $83 a barrel as brief rally stalls out
CNBC
48 minutes ago
Blackstone Mortgage Trust Reports Q1 2024 Results: A Mixed Financial Performance
Yahoo
51 minutes ago
$433 Billion Gone! One Stock Loses More Value Than Tesla
Yahoo
51 minutes ago
PodcastOne (Nasdaq: PODC) Anticipates Record 32% Q4 FY24 Growth; Exclusively Featured in 1.7M Tesla Cars in North America
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
